GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
India’s purchases of crude from Russia are expected to reach 1.855 million barrels per day in November...
California gubernatorial candidate and Democratic Rep. Eric Swalwell said this week that members of the U.S. military have told him...
Trial lawyers have been the bane of U.S. employers and families for many decades, sucking blood out of the economy...
